9,254 followers
Considerable debate in Early disease intervention with clinical genomics - validation, ethnicity variation http://t.co/cVIzxwnIeB @zpleay
Considerable debate in Early disease intervention with clinical genomics - validation, ethnicity variation http://t.co/cVIzxwnIeB @zpleay
Comparison between @23andme, deCODEme (discontinued) and Navigenics (sold to @LIFECorporation). Overlap is not great. http://t.co/07NrCpjqFE
Comparison between @23andme, deCODEme (discontinued) and Navigenics (sold to @LIFECorporation). Overlap is not great. http://t.co/07NrCpjqFE
How accurate are direct to consumer genome tests? http://t.co/YHvdJK6dv4